Form 4 Tracker
ROCKET PHARMACEUTICALS, INC.
RCKT

36 insider filings · Latest: Sep 11, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Sep 11, 2026Sep 16 12:27 AMMartin WilsonGeneral Counsel
Sale
75,364$3.40$256.5K598,489(D)

View →

Sep 15, 2026Sep 15 8:50 PMMilitello John
Proposed Sale
6,897$3.30$22.7K—

View →

Sep 14, 2026Sep 14 7:25 PMMilitello John
Proposed Sale
6,857$3.32$22.7K—

View →

Sep 11, 2026Sep 11 8:57 PMWilson Martin
Proposed Sale
75,364$3.40$256.5K—

View →

Sep 11, 2026Sep 11 8:55 PMMilitello John
Proposed Sale
8,923$3.40$30.4K—

View →

Aug 18, 2026Aug 20 9:30 PMMartin WilsonGeneral Counsel
Sale
631$3.38$2.1K673,853(D)

View →

Aug 18, 2026Aug 20 9:25 PMGaurav ShahCEO
Sale
2,293$3.38$7.8K1,056,594(D)

View →

Aug 18, 2026Aug 18 7:49 PMShah Gaurav
Proposed Sale
2,293$3.38$7.8K—

View →

Aug 18, 2026Aug 18 7:47 PMWilson Martin
Proposed Sale
631$3.38$2.1K—

View →

Aug 18, 2026Aug 18 7:43 PMMilitello John
Proposed Sale
1,252$3.38$4.2K—

View →

Aug 13, 2026Aug 17 9:52 PMGaurav ShahCEO
Sale
2,837$3.38$9.6K1,058,887(D)

View →

Aug 13, 2026Aug 17 9:50 PMMartin WilsonGeneral Counsel
Sale
3,493$3.38$11.8K674,484(D)

View →

Aug 11, 2026Aug 13 8:15 PMChristopher James StevensChief Operating Officer
Sale
36,658$3.50$128.3K505,784(D)

View →

Aug 11, 2026Aug 13 8:15 PMSarbani ChaudhuriChief Commercial & Medical Affairs Officer
Sale
4,701$3.50$16.4K262,809(D)

View →

Aug 13, 2026Aug 13 8:03 PMWilson Martin
Proposed Sale
3,493$3.38$11.8K—

View →

Aug 13, 2026Aug 13 7:39 PMShah Gaurav
Proposed Sale
2,837$3.38$9.6K—

View →

Aug 11, 2026Aug 11 7:30 PMStevens Christopher James
Proposed Sale
36,658$3.50$128.3K—

View →

Aug 11, 2026Aug 11 7:23 PMChaudhuri Sarbani
Proposed Sale
4,701$3.50$16.5K—

View →

Jul 7, 2026Jul 7 7:13 PMMalik Fady Ibraham
Proposed Sale
10,670$3.88$41.4K—

View →

May 21, 2026May 26 11:47 PMGaurav ShahCEO
Sale
55,684$3.09$171.8K1,061,724(D)

View →

Page 1 of 5

Next →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Aug 3, 2026Aug 6 12:49 AMChristopher James StevensChief Operating Officer
Grant/Award
101,428$3.41101,428(D)

View →

Jun 18, 2026Jul 7 12:00 AMRoderick WongDirector, 10% Owner
Grant/Award
78,960$3.3578,960(D)

View →

Jun 18, 2026Jul 7 12:00 AMPeter FongDirector
Grant/Award
64,860$3.3564,860(D)

View →

Jun 18, 2026Jul 6 11:59 PMMikael DolstenDirector
Grant/Award
64,860$3.3564,860(D)

View →

Jun 18, 2026Jul 6 11:59 PMFady Ibraham MalikDirector
Grant/Award
64,860$3.3564,860(D)

View →

Jun 18, 2026Jul 6 11:59 PMDavid P SouthwellDirector
Grant/Award
64,860$3.3564,860(D)

View →

Jun 18, 2026Jul 6 11:59 PMCarsten BoessDirector
Grant/Award
64,860$3.3564,860(D)

View →

May 26, 2026May 28 8:33 PMJohn MilitelloVice President of Finance, Treasurer, Principal Accounting Officer
Disposition
238,256$62.320(D)

View →

May 26, 2026May 28 8:33 PMJohn MilitelloVice President of Finance, Treasurer, Principal Accounting Officer
Grant/Award
116,562$3.009,091(D)

View →

May 21, 2026May 26 11:47 PMGaurav ShahCEO
Option Exercise
76,490$1.690(D)

View →

Feb 11, 2026Feb 13 9:05 PMGaurav ShahCEO
Grant/Award
870,648$3.24870,648(D)

View →

Feb 11, 2026Feb 13 9:05 PMJohn MilitelloOfficer
Grant/Award
45,018$3.2445,018(D)

View →

Feb 11, 2026Feb 13 9:05 PMMartin WilsonGeneral Counsel
Grant/Award
468,187$3.24468,187(D)

View →

Feb 11, 2026Feb 13 9:05 PMSyed Ali-Aamir RizviChief Medical Officer
Grant/Award
93,037$3.2493,037(D)

View →

Feb 11, 2026Feb 13 9:05 PMChristopher James StevensChief Operating Officer
Grant/Award
93,037$3.2493,037(D)

View →

Feb 11, 2026Feb 13 9:05 PMSarbani ChaudhuriChief Commercial & Medical Affairs Officer
Grant/Award
189,076$3.24189,076(D)

View →